•
Dec 31, 2018

BioLife Q4 2018 Earnings Report

Total Revenue
$5.46M
Previous year: $3.13M
+74.1%
EPS
$0.04
Previous year: -$0.05
-180.0%
Gross margin
69%
Adjusted EBITDA
$1.5M
Gross Profit
$3.75M
Previous year: $1.84M
+103.6%
Cash and Equivalents
$30.7M
Previous year: $6.66M
+360.1%
Free Cash Flow
$425K
Previous year: $751K
-43.4%
Total Assets
$45.5M
Previous year: $12.1M
+274.4%

BioLife

BioLife

BioLife Revenue by Segment